Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Hydrarthrosis D006833 1 associated lipids
Gilbert Disease D005878 2 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Intraoperative Complications D007431 5 associated lipids
Arthralgia D018771 8 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Hemophilia A D006467 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Abscess D000038 13 associated lipids
Synovitis D013585 15 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Diarrhea D003967 32 associated lipids
Anaphylaxis D000707 35 associated lipids
Pain D010146 64 associated lipids
Alzheimer Disease D000544 76 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
Singh R et al. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. 2013 AIDS pmid:23014518
Rosette C et al. Anti-inflammatory and immunomodulatory activities of rifamycin SV. 2013 Int. J. Antimicrob. Agents pmid:23756321
Sha W [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis]. 2014 Zhonghua Jie He He Hu Xi Za Zhi pmid:25537407
Chiou WJ et al. In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. 2014 Xenobiotica pmid:23886114
Kawde AN et al. Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes. 2014 Acta Chim Slov pmid:25125124
Evans SE et al. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. 2014 PLoS ONE pmid:24595451
Dechert-Schmitt AM et al. Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. 2014 Nat Prod Rep pmid:24514754
Przybylski P et al. 13C and 15N CP/MAS, 1H-15N SCT CP/MAS and FTIR spectroscopy as tools for qualitative detection of the presence of zwitterionic and non-ionic forms of ansa-macrolide 3-formylrifamycin SV and its derivatives in solid state. 2014 Jan-Feb Magn Reson Chem pmid:24347399
Aygün F et al. The protective effect of topical rifamycin treatment against sternal wound infection in diabetic patients undergoing on-pump coronary artery bypass graft surgery. 2014 May-Jun Cardiovasc J Afr pmid:24687038
Li Q et al. [Ocular syndromes in patients with neurobrucellosis]. 2015 Zhonghua Yan Ke Za Zhi pmid:26888270